National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

recombinant flt3 ligand
A recombinant therapeutic agent which is chemically identical to or similar to the endogenous cytokine Flt3. Flt3 ligand binds to the Flt3 tyrosine kinase receptor and, synergistically with other growth factors, stimulates the proliferation and mobilization of certain bone marrow precursor cells, including CD34+ cells, and dendritic cells. When proteolytically cleaved, the transmembrane isoform of Flt3 ligand generates the soluble form soluble Flt3 ligand , which is also biologically active. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:flt3 ligand
US brand name:Mobist
Abbreviation:rFlt3L



Previous:recombinant adenovirus-L523S vaccine, recombinant adenovirus-p53 SCH-58500, recombinant bispecific single-chain antibody rM28, recombinant CD40-ligand, recombinant dHER2 vaccine
Next:recombinant fowlpox GM-CSF vaccine adjuvant, recombinant fowlpox-B7.1 vaccine, recombinant fowlpox-CEA(6D)/TRICOM vaccine, recombinant fowlpox-prostate apecific antigen vaccine, recombinant fowlpox-TRICOM vaccine

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov